Forging the path for tomorrow therapeutics








19th, 20th July 2024 | Hotel Meridien Hyderabad

Forging the path for tomorrow therapeutics

India Pharma Inc’s next growth phase must be characterised by a shift from volume to value. This, in turn, requires innovation and research capabilities to discover and develop new medicines and therapeutic options for a variety of disease profiles along with a firm commitment to enable accessible and affordable healthcare solutions to patients across the globe.

Hence, FDD Conclave 2024 will focus on the quest for more effective, targeted, and patient-friendly therapeutics, under the theme, ‘Forging the path for tomorrow’s therapeutics. The conclave aims to bring together experts, researchers and thought leaders to explore novel approaches to FR&D and showcase capabilities to develop new molecules, innovative pharma/biopharma products.

FR&D Leaders

The conclave will gather FR&D leaders to discuss how India Pharma Inc can capitalise on its strengths such as technical expertise, cost efficiency, and supportive government policies in its next phase of growth and secure its position in the global pharma R&D landscape.

They will also delve into the advancements, challenges and opportunities in formulation development and drug delivery driven by technological innovation and evolving patient needs.


Through insightful discussions and interactive sessions, the doyens of the FR&D fraternity will cover a plethora of pertinent topics and issues including:

Innovative drug delivery systems (Microneedles, implants, prefilled syringes, self-administered drug delivery systems, transdermal patches etc)

Barriers and challenges such as bioavailability enhancement, solubility issues, stability challenges, excipient selection, lab to market scalability, regulatory approvals etc

Emerging technologies and their applications in FR&D

Patient-centric design for formulation. and delivery to improve therapeutic outcomes

Approaches to build a more cohesive and collatiocative ecosystem between academia, industry and regulatory agencies

Windows of opportunities to accelerate the development and commercialisation of next gen therapeutics

Thus, FDD Conclave 2024 will facilitate progress in the FR&D and contribute through creation of intellectual property, development of novel solutions to address unmet medical needs, enhancement of patient care


Mr Balasubramaniam Jagdish

VP, Formulation Development (PDU), Recipharm Pharmaservices

Dr Shubhadeep D Sinha

Senior VP, Head - Clinical Development & Medical Affairs, Hetero Labs)

Dr Vasanthakumar Ramu

VP, Head of Research and Development - Peptides & Complex API's, Alembic Pharmaceuticals

Mr Elayaraja Natarajan

VP, R&D, Lyrus Life Sciences

Mr Giovanni Costa

Regional Sales Manager, Harro Hoefliger

Mr Prashant Deshpande

Head, Process Technology & Support, ACG

Mr Ravleen Singh Khurana

MD, Nitika Pharmaceuticals Specialties

Mr Abhijit Gothoskar

Technical Expert, Sigachi Industries

Dr Meka Lingam

Senior VP - Formulation R&D, Lee Pharma

Mr Sachin Arora

VP, Delivery Manager - Formulation R&D Oral solids, Dr Reddy's Laboratories

Dr Sumedha Nadkar

Pharmaceutical Consultant and NMIMS - visiting faculty Quality & Regulatory Affairs

Mr Chandresh Chhatbar

VP R&D, CuraTeQ Bilogics

Dr Vivek Kumar Jha

Chief Technical Officer, Cilicant

Ms Komal Bhavsar

AGM - Business Development (Pharma), Cilicant

Mr Satish Chandra Upadhyay

Associate President, Mankind Pharma

Dr Sajeev Chandran

VP, Pharmaceutical R&D, Lupin

Ms Pratibha Pilgaonkar

Co-founder, MD, Board of Directors, Rubicon Research

Suresh Pareek

Angel Investor (Pharma)

Ms Stinita Dsouza

Application Specialist, Equitron Medica

Mr Kamal Kumar Upadhyay

VP- Pharma SGI R&D Head (Injectable), Biological E

Who will attend

Pharmaceutical Formulation Development

Product Development

Pharmaceutical R&D

Technology Transfer

Process Development

Drug Delivery

Delivery Technology

Benefits to you

Conference featuring Subject Matter Experts, Industry Veterans, Partner Presentations Slots

Tracks and Sessions that relate to your business

Brand exposure through multiple Digital opportunities and several event exclusive tie-ins

Pair your session with Guest Speaker/leading CXOs

Multimedia campaign providing a solid buildup to the event, supported by a team of tele-callers

Complete peace of mind knowing this is from Express Pharma and the Indian Express Group

Access to database of all attendees for the entire conference (to select sponsors)


Presenting Partner
Gold Partner
Gold Partner
Gold Partner
Gold Partner
Gold Partner
Gold Partner
Gold Partner
Silver Partner
Silver Partner
Silver Partner
Silver Partner

Express Pharma, first published as Express Pharma Pulse in 1994, is today India’s leading business fortnightly for the pharmaceutical industry. With the patronage of its readers, Express Pharma has grown to become the No.1 Business News Magazine for the pharmaceutical industry. The editorial contents include: news, views, analysis and interviews, under four main segments: Market (The business of pharmaceuticals), Management (Insight for managing pharma), Research (Expertise for drug development) and Pharma Life (HR issues with a pharma focus). Besides this, we bring out periodic specials like the quarterly Pharma Technology Review, Packaging Special and LABNEXT.

Follow us

Copyright & The Indian Express [P] Ltd. All Rights Reserved.